Intro Pullout Text Widget

Drug and Therapeutics Bulletin

(DTB) covers practical, independent and evidence-based information on drugs, medication and prescribing.

Drug and Therapeutics Bulletin (DTB) publishes independent evaluations and practical advice on individual treatments and the overall management of disease. DTB summarises the best available evidence to enable doctors, pharmacists and other healthcare professionals to make informed and unbiased choices to help patients get the best care. DTB is wholly independent of the pharmaceutical industry, government and regulatory authorities and is also free of advertising and other forms of commercial sponsorship.

DTB publishes regular podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Apple, Google, Stitcher and Spotify.

Current Issue

60 years of practical, independent and trusted advice

DTB 60th anniversary podcast interview – John Dowden

27 January, 2023

In a series of interviews to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB.
In the latest interview, David Phizackerley (DTB's deputy editor) talks to Dr John Dowden, the editor of Australian Prescriber since 1990. Australian Prescriber is an independent peer-reviewed journal providing critical commentary on drugs and therapeutics for health professionals, and like DTB, Australian Prescriber was a founder member of the International Society of Drug Bulletins. At the time of recording, John highlighted that public funding for NPS Medicinewise was under threat and unfortunately the Australian Government withdrew funding and the organisation closed at the end of December. The future of Australian Prescriber is uncertain.
We wrote an editorial that criticises the decision to remove funding from NPS Medicinewise and you can find this in the January 2023 issue of DTB